Cancer Therapies

New Drug Destroys Tumor-Feeding Blood Vessels

Published in Blood Weekly, November 23rd, 1998

A cancer patient at the Ireland Cancer Center at University Hospitals of Cleveland, Ohio, is the first person in the world to be treated with a new class of drugs that targets and destroys cancer-feeding blood vessels.

The 55-year-old woman was given the first dose of the drug, Combretastatin, by intravenous infusion on November 9, 1998, at the Ireland Cancer Center. She had been diagnosed in February 1998 with adenocarcinoma, a cancer with an unknown origin. Doctors found malignant tumors in her liver. She underwent two other forms of chemotherapy, which failed, before she volunteered for the Combretastatin study.

Scot C. Remick, MD, program...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1998-11-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry